Does the initial or secondary status of T1G3 bladder tumours have a prognostic impact?
Ouaki F; Irani J; Pires C; Breton X; Levillain P; Dor B Service d’Urologie, Hôpital La Milétrie, Poitiers, France. OBJECTIVE: This retrospective study evaluated the prognostic value of the initial or secondary status of pT1G3 bladder tumours. MATERIALS AND METHODS: Between 1990 and 2000, 93 patients presented with T1G3 bladder tumour. Seventy-five patients, 54 with initial T1G3 and 21 with secondary T1G3, with no history of invasive bladder tumour, were included in the study. Seventy-two per cent were treated by intravesical BCG. No patient received maintenance therapy. The median follow-up was 53 months (range: 2 to 285 months).
